- Home
- Equipment
- switzerland
- prostate tumors
Show results for
Refine by
Prostate Tumors Equipment Supplied In Switzerland
6 equipment items found
Manufactured by:Ferring Pharmaceuticals based inSaint-Prex, SWITZERLAND
FIRMAGON® (degarelix) is a treatment for men with advanced hormone-dependent prostate cancer. It has a novel mechanism of action that is different from traditional LHRH agonist therapy commonly used. Decreasing testosterone levels can cause the cancer cells to die, thus reducing the size of the tumour and delaying its growth. To date, FIRMAGON has been approved in 74 countries. ...
Manufactured by:Ferring Pharmaceuticals based inSaint-Prex, SWITZERLAND
GONAPEPTYL / DECAPEPTYL* (triptorelin acetat) is a solution for injection containing 0.1 mg/1 ml of triptorelin acetate (per prefilled syringe). It is indicated for the down regulation of the pituitary before and during controlled ovarian hyperstimulation in assisted reproduction ...
Manufactured by:Advanced Accelerator Applications SA based inRueil-Malmaison Cedex, FRANCE
LOCAMETZ, after radiolabeling with gallium-68, is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy, with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. for ...
by:Debiopharm based inLausanne, SWITZERLAND
Triptorelin is a gonadotropin releasing hormone (GnRH) agonist; Triptorelin, the active substance of Decapeptyl/Trelstar/Pamorelin/Triptodur, is a GnRH agonist analogue. An agonist is a chemical that binds to a receptor of a cell and triggers a response by that cell. Triptorelin decreases the serum testosterone to castrate levels (estradiol in females). Androgen deprivation stops the growth of ...
Manufactured by:InnoMedicus based inCham, SWITZERLAND
Earlier, precise diagnostic of prostate cancer demands a paradigm change respectively a new treatment pathway. SONABLATE HIFU is the image-guided, non-invasive surgical ablation system that delivers precise, focused and controlled ablative energy and allows to create a customized treatment for each patient’s individual prostate ...
by:Stemline Therapeutics, Inc. based inNew York, NEW YORK (USA)
XPO1 has been shown to regulate nuclear export of many of the major tumor suppressor proteins and oncogenic cell growth regulators. Overexpression of XPO1 has been reported in many cancer types and is associated with aggressive tumor behavior and poor patient prognosis. Inhibition of XPO1 has been shown to restore tumor suppressor function and proper cell cycle regulation, leading to apoptosis of ...